E-Mail
What The Study Did: A clinical risk assessment tool developed in China was tested with a group of patients in Spain to evaluate its ability to predict critical illness among patients hospitalized with COVID-19 in Europe.
Authors: Oscar Moreno-Perez, M.D., Ph.D., of the Alicante General University Hospital-Alicante Institute of Sanitary and Biomedical Research in Alicante, Spain, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https:/